Precision Medicine in Soft Tissue Sarcoma Treatment

Precision Medicine in Soft Tissue Sarcoma Treatment

Soft tissue sarcoma (STS) is a rare component of malignant diseases. STS includes various histological subtypes, and there are some important differences among the different histological subtypes regarding the mutation profile and sensitivity to antitumor agents. Many clinical trials of STS incorpor...

Full description

Bibliographic Details
Main Authors:	Kenji Nakano, Shunji Takahashi
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Cancers
Subjects:	soft tissue sarcoma molecular targeted therapy precision medicine whole genome sequencing
Online Access:	https://www.mdpi.com/2072-6694/12/1/221

Similar Items

Sarcoma treatment in the era of molecular medicine
by: Thomas GP Grünewald, et al.
Published: (2020-11-01)

Precision medicine approaches for the management of Ewing sarcoma: current perspectives
by: Rizk VT, et al.
Published: (2019-01-01)

Targeted therapy for soft tissue sarcomas in adolescents and young adults
by: Steppan DA, et al.
Published: (2017-03-01)

Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy
by: Tuna Musaffe, et al.
Published: (2012-12-01)

Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
by: Kenji Nakano, et al.
Published: (2018-03-01)

Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
by: Xin-Hui Du, et al.
Published: (2020-09-01)

Soft tissue sarcomas: Evaluation by immunohistochemistry
by: Ibtisam Hussein Al Obaidi
Published: (2020-06-01)

The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets
by: Laura Rocchi, et al.
Published: (2014-11-01)

The role of Pazopanib in Soft Tissue Sarcoma: A comprehensive review of the literature
by: Fotopoulos George, et al.
Published: (2015-09-01)

Pazopanib in the management of advanced soft tissue sarcomas
by: Cranmer LD, et al.
Published: (2016-06-01)

Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions
by: Liliana Montella, et al.
Published: (2021-05-01)

Head and neck soft tissue sarcomas treated with radiation therapy
by: Lucas K. Vitzthum, et al.
Published: (2016-06-01)

Actual long-term survival after resection of stage III soft tissue sarcoma
by: Do Weon Lee, et al.
Published: (2021-01-01)

Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
by: Marcella Tazzari, et al.
Published: (2021-07-01)

Systemic chemotherapy of advanced soft tissue sarcomas
by: Mehmet Besiroglu, et al.
Published: (2017-07-01)

Radiation Therapy in Adult Soft Tissue Sarcoma—Current Knowledge and Future Directions: A Review and Expert Opinion
by: Falk Roeder
Published: (2020-11-01)

Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma
by: J. Kevin Hicks, et al.
Published: (2018-10-01)

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial
by: Patrick Arnaud-Coffin, et al.
Published: (2020-12-01)

DETECTION OF RECURRENT SOFT TISSUE SARCOMAS OF EXTREMITIES
by: G. V. Zinovyev, et al.
Published: (2017-06-01)

The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura T, et al.
Published: (2016-01-01)

Pediatric rhabdomyosarcomas and nonrhabdomyosarcoma soft tissue sarcoma
by: Agarwala Sandeep
Published: (2006-01-01)

Ultra-rare Disease and Genomics-Driven Precision Medicine
by: Sangmoon Lee, et al.
Published: (2016-06-01)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
by: Recine F, et al.
Published: (2017-02-01)

Bone and soft tissue sarcomas during pregnancy: A narrative review of the literature
by: George Zarkavelis, et al.
Published: (2016-07-01)

Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
by: Kenji Nakano, et al.
Published: (2019-01-01)

Identification of Novel Fusion Genes in Bone and Soft Tissue Sarcoma and Their Implication in the Generation of a Mouse Model
by: Yasuyo Teramura, et al.
Published: (2020-08-01)

Surgical Management of Soft Tissue Sarcoma
by: Muhammad Mukhtar Khan, et al.
Published: (2018-03-01)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01)

Multimodality treatment of head-and-neck soft-tissue sarcomas and short-term outcomes: Analysis from sarcoma medical oncology clinic
by: Ilavarasi Vanidassane, et al.
Published: (2019-01-01)

Indian data on bone and soft tissue sarcomas: A summary of published study results
by: Anant Ramaswamy, et al.
Published: (2016-01-01)

Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions
by: Neelesh Soman, et al.
Published: (2013-10-01)

Notch signaling in pediatric soft tissue sarcomas
by: Rota Rossella, et al.
Published: (2012-11-01)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
by: Mateusz Jacek Spałek, et al.
Published: (2020-07-01)

Feasibility of chemosensitivity testing in soft tissue sarcomas
by: Steinstraesser Lars, et al.
Published: (2005-04-01)

Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes
by: Ramu Eyal M., et al.
Published: (2017-01-01)

Interstitial brachytherapy for orbital soft tissue sarcoma: an innovative technique
by: Siddhartha Laskar, et al.
Published: (2017-10-01)

Diagnostic Accuracy of Fine Needle Aspiration Cytology in Soft Tissue Sarcomas
by: Soffia Khursheed, et al.
Published: (2018-03-01)

Role of cytology in diagnosis of soft tissue sarcomas with special reference to false positive cases
by: Sengupta Sanjay, et al.
Published: (2009-01-01)

A multimodality approach to the management of soft tissue sarcomas of the extremities, with emphasis on limb preservation.
by: Krawitz, Hedley Eltan
Published: (2018)

Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma
by: Varsha Jain, et al.
Published: (2019-10-01)